ARTICLE | Clinical News
Batu Biologics preclinical data
April 13, 2015 7:00 AM UTC
In mouse models of melanoma, breast cancer and Lewis lung carcinoma (LLC), once-weekly subcutaneous ValloVax for 4 weeks significantly reduced tumor growth and metastasis vs. untreated control placent...